Ronglian Technology (002642): Awarded the procurement project by China People's Health Insurance Co., Ltd., with a bid amount of 7.3488 million yuan.

NightAirdropper · 2026-03-27T21:08:52+00:00

Ronglian Technology wins the People's Health Insurance project with an amount of 7.3488 million yuan. In 2024, operating revenue is expected to be 2.022 billion yuan, with a net profit increase of 107.87%. In the first half of 2025, operating revenue drops to 672 million yuan, with a net profit decrease of 28.57% year-on-year. The company's main business is internet and system integration services.

NightAirdropper

2026-03-27 21:08:52

Abstract generation in progress

Tongbi Finance News, according to data from Qichacha, based on the “Announcement of the Bidding Results for the 2026 Alibaba Cloud Infrastructure Software Maintenance Service Project,” Ronglian Technology Group Co., Ltd. announced on March 27, 2026, that it won the procurement project for China People’s Health Insurance Co., Ltd., with a winning bid amount of 7.3488 million yuan.

Related listed company: Ronglian Technology (002642.SZ)

Tongbi Finance Tips:

Ronglian Technology (002642.SZ) had an operating income of 2.022 billion yuan in 2024, with a growth rate of -14.91%. The net profit attributable to the parent company was 28 million yuan, with a growth rate of 107.87%. The return on net assets was 2.44%.

In the first half of 2025, the company’s operating income was 672 million yuan, with a growth rate of -34.00%. The net profit attributable to the parent company was 8 million yuan, with a growth rate of -28.57%.

Currently, the company belongs to the information technology industry, with the main product types being internet services and system integration services. The 2024 annual report shows the main composition as system integration income: 65.69%; technical services: 24.61%; system products: 9.44%; other businesses: 0.26%.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes